Basel Medical (BMGL) Receivables (2024 - 2025)

Basel Medical (BMGL) posted Receivables of $9.4 million for Q4 2025, up 26.47% sequentially from $7.4 million in Q2 2025, and down 39.98% YoY from $15.6 million in Q4 2024.

Basel Medical (BMGL) Receivables (2024 - 2025) Analysis & Trends

Basel Medical has reported Receivables for 2 years, with the latest figure at $9.4 million in Q4 2025.

  • Quarterly Receivables fell 39.98% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (down 39.98% YoY) and the FY2025 annual result came in at $7.3 million, down 21.77% from the prior year.
  • Receivables advanced to $9.4 million in Q4 2025 per BMGL's latest filing, from $7.4 million in the prior quarter.
  • Over five years, Receivables peaked at $15.6 million in Q4 2024 and troughed at $7.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 12.28 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 2.91 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn 687.30 Mn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 3.03 Bn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn 676.80 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn 2.80 Bn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn 723.91 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 188.63 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn 299.82 Mn
10 Basel Medical 98.81 Mn 98.02 Mn - 9.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 9.35 Mn
Jun 30, 2025 7.39 Mn
Dec 31, 2024 15.58 Mn
Jun 30, 2024 9.04 Mn